Belgium

ONCORADIOMICS (ONCO)

Oncoradiomics is a spin-off company which will achieve more effective, individualized screening & therapy for cancer patients thanks to quantitative imaging. Oncoradiomics has two core proprietary technology platforms to enable this. RadiomiX™ is an innovative imaging analysis software solution that enables the extraction of unique quantitative features (and associated radiomics signatures) from standard images to guide personalized cancer treatment. DistriM™ allows the analysis of large amounts of images in a distributed fashion. Our mission is to enable the right cancer diagnose & treatment for the right patient with quantitative imaging.

Role in the project

ONCO develops and validates an AI solution for semi-automatic liver cancer detection, classification, and reporting from medical images. Furthermore, ONCO leverages its cost-benefit analysis tool and adapt it for the three cancer domains in EuCanImage (liver, colorectal, breast). ONCO has an extensive knowhow on commercialisation and entrepreneurship, which is leveraged in WP7.

https://www.oncoradiomics.com/